News | February 18, 2009

NIH $7.5M Grant to Fund Imaging for Cancer Detection, Monitoring

February 17, 2009 – The National Institutes of Health have given UCSD’s Rebecca and John Moores Cancer Center a $7.5 million grant to develop new methods for detecting cancer and monitoring its treatment at the newly established In Vivo Cellular and Molecular Imaging Center.
“We want to develop diagnostic tools that define the cancer at its earliest stage, not just whether it is there, but its characteristics,” said Robert Mattrey, M.D., co-principal investigator of the project and radiology professor at the UCSD School of Medicine.
Along with pharmacology, chemistry and biochemistry professor — and recent Nobel laureate — Roger Tsien, Mattrey will lead a project to improve strategies for detecting enzymes called matrix metalloproteinases, which aggressively break down tissue and enable cancers to spread. The research team is developing imaging tools for conducting ultrasounds that will help detect enzymes in prostate and breast cancers.
Mattrey said that clearly determining the aggressiveness of a cancer will likely influence the treatment decisions of both doctors and patients.
In another project, co-principal investigator and professor of radiology David Vera, Ph.D., will collaborate with medicine professor Stephen Howell, M.D., to use nuclear imaging and ultrasounds in virtually tracking cancer cells and monitoring the effectiveness of an experimental, platinum-based chemotherapy drug.
“It’s difficult to know if a drug is reaching its molecular target,” Mattrey said. “It’s not just a matter of knowing that the drug reaches the tumor, but also if it was able to inhibit or stop the chemical reaction that it was designed to do.”
A portion of the grant will also fund a study led by assistant professor of pathology Dwayne Stupack, Ph.D., involving the use of nanoparticles to detect changes in the blood vessels associated with tumors. Stupack hopes to develop an imaging system that will expose tumors in their earliest stages.

Source: The Guardian, University of California, San Diego

For more information: www.ucsdguardian.org

Related Content

NIH Study of Brain Energy Patterns Provides New Insights into Alcohol Effects

NIH scientists present a new method for combining measures of brain activity (left) and glucose consumption (right) to study regional specialization and to better understand the effects of alcohol on the human brain. Image courtesy of Ehsan Shokri-Kojori, Ph.D., of NIAAA.

News | Neuro Imaging | March 22, 2019
March 22, 2019 — Assessing the patterns of energy use and neuronal activity simultaneously in the human brain improve
Improving Molecular Imaging Using a Deep Learning Approach
News | Nuclear Imaging | March 21, 2019
Generating comprehensive molecular images of organs and tumors in living organisms can be performed at ultra-fast speed...
PET Scans Show Biomarkers Could Spare Some Breast Cancer Patients from Chemotherapy
News | PET Imaging | March 18, 2019
A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which...
Researchers Create New Method for Developing Cancer Imaging Isotopes

Prototype fluidic system for zirconium-89 purification. Image taken through a hot cell window at the Department of Radiology, University of Washington. Image courtesy of Matthew O’Hara, Pacific Northwest National Laboratory

News | Radiopharmaceuticals and Tracers | March 14, 2019
A team of researchers at the University of Washington announced they developed a new automated system for producing...
Siemens Healthineers Announces First U.S. Install of Biograph Vision PET/CT
News | PET-CT | March 06, 2019
Siemens Healthineers’ new Biograph Vision positron emission tomography/computed tomography (PET/CT) system has been...
ImaginAb Enrolls First Patient in Phase II PET Agent Clinical Trial
News | Radiopharmaceuticals and Tracers | January 30, 2019
ImaginAb Inc. announced the enrollment of the first patient in the Phase II clinical trial of the company’s CD8+ T Cell...
FDA Clears United Imaging Healthcare uExplorer Total-Body Scanner
Technology | PET-CT | January 23, 2019
January 23, 2019 — United Imaging Healthcare (United Imaging) announced U.S.
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
FDA Approves Exablate Neuro for Tremor-Dominant Parkinson's Treatment
Technology | Focused Ultrasound Therapy | December 21, 2018
Insightec announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication of...